SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-18-000750
Filing Date
2018-02-14
Accepted
2018-02-14 10:01:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSONANCE CAPITAL MANAGEMENT LP clvsa1_21418.htm SC 13G/A 53357
  Complete submission text file 0001085146-18-000750.txt   54904
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86488 | Film No.: 18608212
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

IRS No.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A